重症或危重型COVID-19住院患者主动脉炎症反应的时间相关性:COVAIR研究——基于18F-FDG PET/CT的评估
这项先导性病例对照研究于2020年11月至2021年5月纳入20例重症或危重型COVID-19患者(平均年龄59±12岁)和10例年龄性别匹配对照,在入院后20-120天行18F-FDG PET/CT评估主动脉炎症。患者与对照的主动脉摄取无显著差异,但主动脉靶本比与入院至扫描时间呈中度负相关,≤60天扫描者GLA-TBR和IAS-TBR均显著高于>60天者,IAS-TBR也显著高于对照。作者认为这是首次提示重症或危重型COVID-19早期恢复阶段主动脉炎症增高并随时间大部分消退的研究。
要点
- 重症或危重型COVID-19患者与对照的主动脉18F-FDG摄取无显著差异(GLA-TBR P=0.422,IAS-TBR P=0.155)。
- 主动脉TBR与入院至扫描时间呈中度负相关(GLA rho=-0.528,P=0.017;IAS rho=-0.480,P=0.032)。
- 入院≤60天扫描者GLA-TBR和IAS-TBR均显著高于>60天扫描者(P=0.016和P=0.038)。
核心结论
- 这是首次提示重症或危重型COVID-19患者早期恢复阶段18F-FDG PET/CT评估的主动脉炎症增高并随时间大部分消退的研究。
- 作者认为该发现可能对理解疾病病程和改进预防与治疗策略有重要意义。
研究设计与样本
- 先导性病例对照研究,于2020年11月至2021年5月招募20例重症或危重型COVID-19患者(平均年龄59±12岁),以10例年龄和性别匹配个体为对照组。
- 在入院后20-120天行18F-FDG PET/CT,测量主动脉摄取,计算全局主动脉靶本比(GLA-TBR)和指数主动脉节段靶本比(IAS-TBR)。
主要发现
- 患者与对照的GLA-TBR分别为1.46(1.40-1.57)和1.43(1.32-1.70),P=0.422,无显著差异。
- 患者与对照的IAS-TBR分别为1.60(1.50-1.67)和1.50(1.42-1.61),P=0.155,无显著差异。
- GLA-TBR与入院至扫描时间呈中度负相关(Spearman's rho=-0.528,P=0.017),IAS-TBR亦呈中度负相关(Spearman's rho=-0.480,P=0.032)。
- 入院≤60天扫描者(n=11)GLA-TBR为1.53(1.42-1.60),>60天者为1.40(1.33-1.45),P=0.016;IAS-TBR分别为1.64(1.51-1.74)和1.52(1.46-1.60),P=0.038。
- 入院≤60天扫描者与对照的IAS-TBR分别为1.64(1.51-1.74)和1.50(1.41-1.61),P=0.036,差异显著。
关键数值与推荐
- GLA-TBR定义为升主动脉、降主动脉、主动脉弓和腹主动脉TBR之和除以4。
- IAS-TBR定义为TBR最高的主动脉节段。
- 患者与对照的GLA-TBR分别为1.46(1.40-1.57)和1.43(1.32-1.70),P=0.422。
- 患者与对照的IAS-TBR分别为1.60(1.50-1.67)和1.50(1.42-1.61),P=0.155。
- 入院≤60天扫描者(n=11)与>60天者的GLA-TBR分别为1.53(1.42-1.60)和1.40(1.33-1.45),P=0.016;IAS-TBR分别为1.64(1.51-1.74)和1.52(1.46-1.60),P=0.038。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Arterial involvement has been implicated in the coronavirus disease of 2019 (COVID-19). Fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) imaging is a valuable tool for the assessment of aortic inflammation and is a predictor of outcome. We sought to prospectively assess the presence of aortic inflammation and its time-dependent trend in patients with COVID-19. METHODS: Between November 2020 and May 2021, in this pilot, case-control study, we recruited 20 patients with severe or critical COVID-19 (mean age of 59 ± 12 years), while 10 age and sex-matched individuals served as the control group. Aortic inflammation was assessed by measuring 18F-FDG uptake in PET/CT performed 20-120 days post-admission. Global aortic target to background ratio (GLA-TBR) was calculated as the sum of TBRs of ascending and descending aorta, aortic arch, and abdominal aorta divided by 4. Index aortic segment TBR (IAS-TBR) was designated as the aortic segment with the highest TBR. RESULTS: There was no significant difference in aortic 18F-FDG PET/CT uptake between patients and controls (GLA-TBR: 1.46 [1.40-1.57] vs. 1.43 [1.32-1.70], respectively, P = 0.422 and IAS-TBR: 1.60 [1.50-1.67] vs. 1.50 [1.42-1.61], respectively, P = 0.155). There was a moderate correlation between aortic TBR values (both GLA and IAS) and time distance from admission to 18F-FDG PET-CT scan (Spearman's rho = - 0.528, P = 0.017 and Spearman's rho = - 0.480, p = 0.032, respectively). Patients who were scanned less than or equal to 60 days from admission (n = 11) had significantly higher GLA-TBR values compared to patients that were examined more than 60 days post-admission (GLA-TBR: 1.53 [1.42-1.60] vs. 1.40 [1.33-1.45], respectively, P = 0.016 and IAS-TBR: 1.64 [1.51-1.74] vs. 1.52 [1.46-1.60], respectively, P = 0.038). There was a significant difference in IAS- TBR between patients scanned ≤ 60 days and controls (1.64 [1.51-1.74] vs. 1.50 [1.41-1.61], P = 0.036). CONCLUSION: This is the first study suggesting that aortic inflammation, as assessed by 18F-FDG PET/CT imaging, is increased in the early post COVID phase in patients with severe or critical COVID-19 and largely resolves over time. Our findings may have important implications for the understanding of the course of the disease and for improving our preventive and therapeutic strategies.
引用
- Vlachopoulos C, Terentes-Printzios D, Katsaounou P, et al. Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study. J Nucl Cardiol. 2022. PMID: 35501458. doi:10.1007/s12350-022-02962-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。